CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- 4 Open-market buy President & CEO bought 65,000 shares at $1.66 ($107,822)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 12,500 shares at $4.00 ($50,000)
- 4 Open-market buy 10% owner bought 250,000 shares at $4.00 ($1,000,000)
- 4 Open-market buy Chief Technology Officer bought 5,000 shares at $4.00 ($20,000)
- 4 Open-market buy Chief Retail Officer bought 5,000 shares at $4.00 ($20,000)
- 4 Open-market buy VP of Finance bought 5,000 shares at $4.00 ($20,000)
- 4 Open-market buy Exec Chairman of the Board bought 12,500 shares at $4.00 ($50,000)
- 4 Open-market buy President & CFO bought 12,500 shares at $4.00 ($50,000)
- 4 Open-market buy Chief Clinical & Reg Officer bought 2,500 shares at $4.00 ($10,000)
- 4 Open-market buy Director bought 6,250 shares at $4.00 ($25,000)
- 4 Open-market buy Director bought 7,500 shares at $4.00 ($30,000)
- 4 Open-market buy 10% owner bought 25,000 shares at $4.00 ($100,000)
- 4 Grant or award Director acquired 78,125 shares (grant or award)
- 4 Grant or award Director acquired 78,125 shares (grant or award)
Page 5 of 13 · 243 filings